ProKidney Corp. (PROK) Misses Q3 EPS by 1c

ProKidney Corp. (NASDAQ: PROK) reported Q3 EPS of ($0.14), $0.01 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on ProKidney Corp. (PROK) click here.

You May Also Be Interested In

• Lyntris opens at $15.50, below IPO price of $17.50
• Maravai LifeSciences (MRVI) call put ratio 22 calls to 1 put with a focus on December 5, 7.5 and 10 calls as share price up 25%
• Cantor Fitzgerald launches prediction market trading for institutions